Argentina

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 23:19, November 18, 2016 by Samsara (talk | contribs) (+cat)
Argentina

-brief description-

Medical guidelines

National health department

Government health insurance

Private health insurance

Access to care

Ampligen has been approved for use by the Argentine Republic for ME/CFS as of August 23, 2016.[1]

Social security and disability benefits

Patient charities

Research

Research groups

Researchers

Clinicians

Notable patients

Deceased patients

Learn more

See also

References

  1. ↑ Hemispherx Biopharma Announces Major Breakthrough: Approval for Commercial Sale of Rintatolimod (U.S. Tradename: Ampligen®) to Treat Severe Cases of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in the Argentine Republic - NasDaq GlobeNewswire
Retrieved from "https://me-pedia.org/w/index.php?title=Argentina&oldid=19074"